CG Invites Co., Ltd. (KOSDAQ:083790)
1,438.00
+8.00 (0.56%)
Mar 12, 2026, 2:04 PM KST
CG Invites Market Cap
CG Invites has a market cap or net worth of 109.96 billion as of March 11, 2026. Its market cap has decreased by -36.73% in one year.
Market Cap
109.96B
Enterprise Value
164.25B
Revenue
18.12B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,438.00
Market Cap Chart
Since January 6, 2006, CG Invites's market cap has decreased from 137.39B to 109.96B, a decrease of -19.96%. That is a compound annual growth rate of -1.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 11, 2026 | 109.96B | -3.83% |
| Dec 30, 2025 | 114.34B | -38.17% |
| Dec 30, 2024 | 184.93B | -11.21% |
| Dec 28, 2023 | 208.28B | -13.64% |
| Dec 29, 2022 | 241.17B | -46.50% |
| Dec 30, 2021 | 450.79B | -45.11% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genexine | 223.76B |
| Vaxcell-Bio Therapeutics | 190.71B |
| Macrogen | 178.34B |
| MedPacto | 170.18B |
| ENCell | 167.87B |
| iNtRON Biotechnology | 149.60B |
| Amicogen | 95.46B |
| IMB Dx | 94.48B |